STEPHANIE GARCIA: Open Payments
NPI 1851985832 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 47 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $573 · 2025 $956
Food & beverage: $890Education: $66
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $307 |
| AstraZeneca Pharmaceuticals LP | 13 | $221 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| GENZYME CORPORATION | 4 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $74 |
| Optinose US, Inc. | 4 | $71 |
| Genentech USA, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Verona Pharma, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: DUPIXENT, AIRSUPRA, NEFFY, FASENRA, Xhance, Xolair, TEZSPIRE, Rhapsido.
Industry payments across MO — which companies pay providers there.
